Centrient Pharmaceuticals
Centrient Pharmaceuticals, headquartered in the Netherlands, is a leading player in the global pharmaceutical industry, specialising in the development and manufacturing of essential antibiotics and anti-infectives. Founded in 2017, the company has quickly established itself as a key provider of high-quality, sustainable pharmaceutical solutions, with a strong operational presence across Europe, Asia, and North America.
Centrient's core offerings include a diverse range of generic and branded antibiotics, as well as innovative formulations that address critical healthcare needs. The company is recognised for its commitment to sustainability and responsible manufacturing practices, setting it apart in a competitive market. With a focus on quality and patient safety, Centrient Pharmaceuticals continues to achieve significant milestones, reinforcing its position as a trusted partner in the healthcare sector.
+17 vs industry average
Centrient Pharmaceuticals’s score of 55 is higher than 72% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Centrient Pharmaceuticals?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Pharmaceutical Preparation Manufacturing has below-average carbon intensity
Industry performance
The Pharmaceutical Preparation Manufacturing industry has reduced its overall emissions by 19% since 0
Emissions trajectory 2020 – 2027
Reported emissions
Scope 3 accounts for ••• of total emissions.
Centrient Pharmaceuticals's reported carbon emissions
In 2024, Centrient Pharmaceuticals reported total carbon emissions of approximately 697 million kg CO2e, comprising 142.9 million kg CO2e from Scope 1, 118.1 million kg CO2e from Scope 2, and 436.1 million kg CO2e from Scope 3 emissions. This represents a decrease from 2023, where total emissions were approximately 733 million kg CO2e. The company has set ambitious targets to reduce its greenhouse gas emissions, committing to a 46.2% absolute reduction in Scope 1 and 2 emissions by 2031, using 2022 as the baseline year. Additionally, Centrient aims for a 27.5% reduction in Scope 3 emissions from purchased goods and services and fuel and energy-related activities within the same timeframe. These targets align with the Science Based Targets initiative (SBTi) and are consistent with efforts to limit global warming to 1.5°C. The company has also achieved a 7.5% reduction in emissions intensity from 2021 to 2023. Centrient Pharmaceuticals is headquartered in the Netherlands and is part of the pharmaceuticals, biotechnology, and life sciences sector.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Centrient Pharmaceuticals’s Climate Goals (2030 & 2050)
3 goals2025
35% reduction in all scopes
35% reduction in carbon emission intensity (2025) and 50% by 2030*
2030
62% reduction in total GHG
Vs 2019 baseline. Validated by SBTi. Includes full supply chain.
2040
50% reduction in Scope 3 intensity
Across purchased goods and services and logistics.
See all 3 climate goals
Already have an account? Sign in now
Scope 3 top emissions categories
1 of 15 categories disclosedSee all scope 3 categories
Already have an account? Sign in now
Climate initiatives

Science Based Targets Initiative

Carbon Disclosure Project
The Climate Pledge
UN Global Compact Climate Champions initiative
RE 100
Climate Action 100
Emissions comparison with industry peers
View similar organisationsFrequently asked questions
Common questions about Centrient Pharmaceuticals’s sustainability data and climate commitments
Data year: 2024
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project